The COVID-19 pandemic has accelerated the adoption of wearable technology in healthcare, particularly in remote monitoring and telemedicine. Wearables such as smartwatches and medical-grade devices are now essential tools for managing chronic conditions like diabetes, providing real-time glucose monitoring. For example, Apple Watch users can now access glucose data directly from older DexCom continuous glucose monitoring (CGM) devices, eliminating the need for data relay through iPhones and providing immediate access to critical health information.
The wearable technology market is projected to experience significant growth in the coming years, driven by innovations in hearables and smartwatches. By 2030, the market is expected to reach a value of $290.6 billion, up from $99.5 billion in 2022. Advances in AI are also enhancing wearable devices, offering more interactive and intelligent features. The latest Dexcom G7 exemplifies this trend, showcasing direct Bluetooth connectivity with smartphones and Apple Watch for real-time glucose monitoring.
The use of wearable technology is reshaping diabetes management, promoting a connected and proactive approach beyond the challenges of the pandemic. As healthcare professionals and patients continue to embrace these technologies, healthcare practices are transforming to make monitoring and managing chronic conditions more efficient and accessible. Wearable technology is playing a crucial role in this transformation, offering users greater control over their health and well-being.
In summary, the adoption of wearable technology in healthcare has been rapidly accelerated by the COVID-19 pandemic, particularly in areas like remote monitoring and telemedicine. Wearables such as smartwatches and medical-grade devices are now essential tools for managing chronic conditions like diabetes, providing real-time glucose monitoring. The wearable technology market is expected to see significant growth in the coming years, driven by innovations in hearables and smartwatches
